HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference30 articles.
1. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005;Goldhirsch;Ann Oncol,2005
2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001
3. Estrogen receptor-positive, progesterone receptor-negativebreast cancer: association with growth factor receptor expression and tamoxifen resistance;Arpino;J Natl Cancer Inst,2005
4. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005
5. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005
Cited by 131 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analytical methods for evaluating and characterizing recombinant proteins;Fundamentals of Recombinant Protein Production, Purification and Characterization;2025
2. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors;PeerJ;2024-05-15
3. Metastasis to the bladder from primary breast cancer: A case report and literature review;Oncology Letters;2024-04-05
4. Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients;Breast Cancer: Targets and Therapy;2024-04
5. Advances in PET/CT Imaging for Breast Cancer;Journal of Clinical Medicine;2023-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3